You have access
Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with Nivolumab
YOSHIHIKO TANIGUCHI, AKIHIRO TAMIYA, SYUN-ICHI ISA, KENJI NAKAHAMA, KYOICHI OKISHIO, TAKAYUKI SHIROYAMA, HIDEKAZU SUZUKI, TAKAKO INOUE, MOTOHIRO TAMIYA, TOMONORI HIRASHIMA, FUMIO IMAMURA and SHINJI ATAGI
Anticancer Research October 2017, 37 (10) 5857-5862;
